157 related articles for article (PubMed ID: 31054253)
1. Actinin-4 as a Diagnostic Biomarker in Serum of Breast Cancer Patients.
Fang C; Li JJ; Deng T; Li BH; Geng PL; Zeng XT
Med Sci Monit; 2019 May; 25():3298-3302. PubMed ID: 31054253
[TBL] [Abstract][Full Text] [Related]
2. Serum Actinin-4 Levels as a Potential Diagnostic and Prognostic Marker in Cervical Cancer.
Ma X; Xue H; Zhong J; Feng B; Zuo Y
Dis Markers; 2020; 2020():5327378. PubMed ID: 32855746
[TBL] [Abstract][Full Text] [Related]
3. Circulating lncRNA H19 in plasma as a novel biomarker for breast cancer.
Zhang K; Luo Z; Zhang Y; Zhang L; Wu L; Liu L; Yang J; Song X; Liu J
Cancer Biomark; 2016 Jun; 17(2):187-94. PubMed ID: 27540977
[TBL] [Abstract][Full Text] [Related]
4. Increased expression of α-actinin-4 is associated with unfavorable pathological features and invasiveness of bladder cancer.
Yoshii H; Ito K; Asano T; Horiguchi A; Hayakawa M; Asano T
Oncol Rep; 2013 Sep; 30(3):1073-80. PubMed ID: 23817592
[TBL] [Abstract][Full Text] [Related]
5. Alpha-actinin 4 is associated with cancer cell motility and is a potential biomarker in non-small cell lung cancer.
Wang MC; Chang YH; Wu CC; Tyan YC; Chang HC; Goan YG; Lai WW; Cheng PN; Liao PC
J Thorac Oncol; 2015 Feb; 10(2):286-301. PubMed ID: 25299231
[TBL] [Abstract][Full Text] [Related]
6. The potential value of serum chemerin in patients with breast cancer.
Song Y; Zhu X; Lin Z; Luo L; Wen D
Sci Rep; 2021 Mar; 11(1):6564. PubMed ID: 33753802
[TBL] [Abstract][Full Text] [Related]
7. Clinical potential of miR-940 as a diagnostic and prognostic biomarker in breast cancer patients.
Liu W; Xu Y; Guan H; Meng H
Cancer Biomark; 2018; 22(3):487-493. PubMed ID: 29843213
[TBL] [Abstract][Full Text] [Related]
8. Plasma Circulating Cell-free Nuclear and Mitochondrial DNA as Potential Biomarkers in the Peripheral Blood of Breast Cancer Patients.
Mahmoud EH; Fawzy A; Ahmad OK; Ali AM
Asian Pac J Cancer Prev; 2015; 16(18):8299-305. PubMed ID: 26745076
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic Value of Serum Concentration and Integrity of Circulating Cell-Free DNA in Breast Cancer: A Comparative Study With CEA and CA15-3.
Tang Z; Li L; Shen L; Shen X; Ju S; Cong H
Lab Med; 2018 Oct; 49(4):323-328. PubMed ID: 29701836
[TBL] [Abstract][Full Text] [Related]
10. Prognostic significance of gene amplification of ACTN4 in stage I and II oral tongue cancer.
Kakuya T; Mori T; Yoshimoto S; Watabe Y; Miura N; Shoji H; Onidani K; Shibahara T; Honda K
Int J Oral Maxillofac Surg; 2017 Aug; 46(8):968-976. PubMed ID: 28385383
[TBL] [Abstract][Full Text] [Related]
11. Serum Tumor Marker Levels might have Little Significance in Evaluating Neoadjuvant Treatment Response in Locally Advanced Breast Cancer.
Wang YJ; Huang XY; Mo M; Li JW; Jia XQ; Shao ZM; Shen ZZ; Wu J; Liu GY
Asian Pac J Cancer Prev; 2015; 16(11):4603-8. PubMed ID: 26107211
[TBL] [Abstract][Full Text] [Related]
12. Pleiotrophin as a potential biomarker in breast cancer patients.
Ma J; Kong Y; Nan H; Qu S; Fu X; Jiang L; Wang W; Guo H; Zhao S; He J; Nan K
Clin Chim Acta; 2017 Mar; 466():6-12. PubMed ID: 28041942
[TBL] [Abstract][Full Text] [Related]
13. Alpha-actinin 4 and tumorigenesis of hepatocellular carcinoma.
Wang G; Li Y; Tang B; Yu Q
Transl Cancer Res; 2019 Aug; 8(4):1374-1380. PubMed ID: 35116880
[TBL] [Abstract][Full Text] [Related]
14. Serum Dickkopf-1 acts as a new biomarker in human breast cancer.
Liu JT; Guo WB; Sun JY
Minerva Med; 2017 Aug; 108(4):334-340. PubMed ID: 28248066
[TBL] [Abstract][Full Text] [Related]
15. [Long non-coding RNA HOTAIR in plasma as a potential biomarker for breast cancer diagnosis].
Zhang KJ; Zhang Y; Luo ZL; Liu L; Yang J; Wu LC; Yu SS; Liu JB
Nan Fang Yi Ke Da Xue Xue Bao; 2016 Apr; 36(4):488-92. PubMed ID: 27113175
[TBL] [Abstract][Full Text] [Related]
16. Measurement of copy number of ACTN4 to optimize the therapeutic strategy for locally advanced pancreatic cancer.
Shoji H; Miura N; Ueno H; Honda K
Pancreatology; 2018 Sep; 18(6):624-629. PubMed ID: 29921500
[TBL] [Abstract][Full Text] [Related]
17. Circulating microRNAs from the miR-106a-363 cluster on chromosome X as novel diagnostic biomarkers for breast cancer.
Li M; Zhou Y; Xia T; Zhou X; Huang Z; Zhang H; Zhu W; Ding Q; Wang S
Breast Cancer Res Treat; 2018 Jul; 170(2):257-270. PubMed ID: 29557526
[TBL] [Abstract][Full Text] [Related]
18. Expression of serum miR-218 in hepatocellular carcinoma and its prognostic significance.
Yang L; Xu Q; Xie H; Gu G; Jiang J
Clin Transl Oncol; 2016 Aug; 18(8):841-7. PubMed ID: 26586116
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of adjuvant chemotherapy for non-small cell lung cancer assessed by metastatic potential associated with ACTN4.
Miura N; Kamita M; Kakuya T; Fujiwara Y; Tsuta K; Shiraishi H; Takeshita F; Ochiya T; Shoji H; Huang W; Ohe Y; Yamada T; Honda K
Oncotarget; 2016 May; 7(22):33165-78. PubMed ID: 27121206
[TBL] [Abstract][Full Text] [Related]
20. Investigation of serum miR-411 as a diagnosis and prognosis biomarker for non-small cell lung cancer.
Wang SY; Li Y; Jiang YS; Li RZ
Eur Rev Med Pharmacol Sci; 2017 Sep; 21(18):4092-4097. PubMed ID: 29028091
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
